Skip to main content
. Author manuscript; available in PMC: 2015 Jan 25.
Published in final edited form as: Mol Cell Endocrinol. 2013 Apr 4;382(1):10.1016/j.mce.2013.03.016. doi: 10.1016/j.mce.2013.03.016

Table 2.

Developmental abnormalities associated with CDK4 and CDK6 deficiency

Disrupted
gene(s)
Survival Pathology References
CDK4 viable Small body size. Most males are sterile due to
hypoplastic testes and low sperm counts.
Female sterility is due to defects in the
hypothalmic–pituitary axis, abnormal estrus,
and failure of corpus luteum. Abnormal
development of pancreatic β-islet cells leads to
insulin-dependent diabetes within the first 2
months of life. MEFs can be propagated in
culture with decreased ability to enter the cell
cycle from quiescence; they express aberrantly
high levels of p21Cip1 and resist
transformation by oncogenic Ras + DN-p53.
(Moons et al., 2002a;
Moons et al., 2002b;
Rane et al., 1999;
Tsutsui et al., 1999;
Zou et al., 2002)
CDK6 viable Thymic and splenic hypoplasia, and mild
defects in hematopoiesis. T-lymphocytes
exhibit delayed S-phase entry.
(Malumbres et al., 2004)
CDK4 and
CDK6
progressive
embryonic lethality
from E14.5
onward; a few
pups die after birth.
Small embryos. Partial failure of hematopoiesis
results from reduced multi-potential
progenitors and multi-lineage deficits, including
severe megaloblastic anemia. MEFs proliferate
with increased generation time and reduced Sphase
fraction. Some D-type Cyclins associate
with and activate CDK2. MEFs resist
transformation.
(Malumbres et al., 2004)